$0 is the total value of Altitude Crest Partners Inc.'s 1 reported holdings in Q2 2024. The portfolio turnover from Q1 2024 to Q2 2024 was 103.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | No securities0 | $0 | – | 0 | +100.0% | 0.00% | – | |
| Exit | SURROZEN INC*w exp 08/01/203 | $0 | – | -384,573 | -100.0% | -0.01% | – | |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -200 | -100.0% | -0.01% | – |
| Exit | TOURMALINE BIO INC | $0 | – | -47,400 | -100.0% | -0.46% | – | |
| Exit | METAGENOMI INC | $0 | – | -133,333 | -100.0% | -0.60% | – | |
| Exit | ZYMEWORKS INC | $0 | – | -145,581 | -100.0% | -0.66% | – | |
| APLT | Exit | APPLIED THERAPEUTICS INC | $0 | – | -259,700 | -100.0% | -0.76% | – |
| Exit | ENGENE HOLDINGS INC | $0 | – | -120,289 | -100.0% | -0.87% | – | |
| ALGS | Exit | ALIGOS THERAPEUTICS INC | $0 | – | -2,844,681 | -100.0% | -1.19% | – |
| DAWN | Exit | DAY ONE BIOPHARMACEUTICALS I | $0 | – | -195,497 | -100.0% | -1.38% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -113,100 | -100.0% | -1.42% | – |
| Exit | CORBUS PHARMACEUTICALS HLDGS | $0 | – | -103,703 | -100.0% | -1.74% | – | |
| DNLI | Exit | DENALI THERAPEUTICS INC | $0 | – | -209,613 | -100.0% | -1.84% | – |
| Exit | ROIVANT SCIENCES LTD | $0 | – | -454,766 | -100.0% | -2.05% | – | |
| MRUS | Exit | MERUS N V | $0 | – | -109,837 | -100.0% | -2.12% | – |
| ICLR | Exit | ICON PLC | $0 | – | -14,800 | -100.0% | -2.13% | – |
| GERN | Exit | GERON CORP | $0 | – | -1,531,400 | -100.0% | -2.16% | – |
| SWTX | Exit | SPRINGWORKS THERAPEUTICS INC | $0 | – | -128,842 | -100.0% | -2.72% | – |
| IMNM | Exit | IMMUNOME INC | $0 | – | -262,284 | -100.0% | -2.77% | – |
| Exit | BIOHAVEN LTD | $0 | – | -118,380 | -100.0% | -2.77% | – | |
| LLY | Exit | ELI LILLY & CO | $0 | – | -9,200 | -100.0% | -3.06% | – |
| JANX | Exit | JANUX THERAPEUTICS INC | $0 | – | -193,300 | -100.0% | -3.12% | – |
| KNSA | Exit | KINIKSA PHARMACEUTICALS LTD | $0 | – | -400,441 | -100.0% | -3.38% | – |
| Exit | STRUCTURE THERAPEUTICS INCsponsored ads | $0 | – | -205,166 | -100.0% | -3.76% | – | |
| Exit | ARRIVENT BIOPHARMA INC | $0 | – | -555,555 | -100.0% | -4.25% | – | |
| TMO | Exit | THERMO FISHER SCIENTIFIC INC | $0 | – | -18,400 | -100.0% | -4.58% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -287,277 | -100.0% | -7.23% | – |
| Exit | STEVANATO GROUP S P A | $0 | – | -550,000 | -100.0% | -7.56% | – | |
| BBIO | Exit | BRIDGEBIO PHARMA INC | $0 | – | -612,060 | -100.0% | -8.10% | – |
| DHR | Exit | DANAHER CORPORATION | $0 | – | -108,700 | -100.0% | -11.62% | – |
| LEGN | Exit | LEGEND BIOTECH CORPsponsored ads | $0 | – | -652,732 | -100.0% | -15.67% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LEGEND BIOTECH CORP | 2 | Q1 2024 | 21.8% |
| DANAHER CORPORATION | 2 | Q1 2024 | 18.8% |
| BRIDGEBIO PHARMA INC | 2 | Q1 2024 | 20.4% |
| APELLIS PHARMACEUTICALS INC | 2 | Q1 2024 | 7.2% |
| KINIKSA PHARMACEUTICALS LTD | 2 | Q1 2024 | 5.4% |
| ROIVANT SCIENCES LTD | 2 | Q1 2024 | 6.1% |
| ALIGOS THERAPEUTICS INC | 2 | Q1 2024 | 1.3% |
| SURROZEN INC | 2 | Q1 2024 | 0.0% |
| STEVANATO GROUP S P A | 1 | Q1 2024 | 7.6% |
| ARGENX SE | 1 | Q4 2023 | 7.5% |
View Altitude Crest Partners Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
View Altitude Crest Partners Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.